We are live on ! Find out more
ATXS

Astria Therapeutics

Delisted

ATXS was delisted on the 22nd of January, 2026.

Name Holding Trade Value Shares
Change
Change in
Stake
PA
1
Perceptive Advisors
New York
$5.59M +$5.82M +322,259 New
SFM
2
Sphera Funds Management
Israel
$3.74M +$3.9M +215,667 New
BlackRock
3
BlackRock
New York
$3.52M +$157K +8,699 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.52M +$151K +8,332 +6%
IC
5
Ikarian Capital
Texas
$2.46M +$611K +33,833 +31%
SCM
6
Soleus Capital Management
Connecticut
$2.24M +$2.33M +129,167 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$2.11M +$2.2M +121,884 New
State Street
8
State Street
Massachusetts
$1.59M +$551K +30,509 +50%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$884K +$178K +9,869 +24%
Northern Trust
10
Northern Trust
Illinois
$745K -$99.7K -5,518 -11%
Renaissance Technologies
11
Renaissance Technologies
New York
$517K +$539K +29,843 New
PPA
12
Parametric Portfolio Associates
Washington
$495K +$427K +23,653 +482%
AI
13
ArchPoint Investors
Florida
$471K +$490K +27,138 New
SB
14
Samsara BioCapital
California
$434K -$452K -25,000 -50%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$366K +$172K +9,527 +82%
BCM
16
Bridgeway Capital Management
Texas
$311K +$286K +15,850 +761%
Morgan Stanley
17
Morgan Stanley
New York
$306K -$1.56M -86,489 -83%
CCP
18
Corient Capital Partners
California
$299K +$312K +17,254 New
Group One Trading
19
Group One Trading
Illinois
$292K +$305K +16,860 New
BFM
20
Boothbay Fund Management
New York
$276K +$79.3K +4,388 +38%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$246K +$125K +6,900 +95%
Nuveen
22
Nuveen
North Carolina
$241K +$16.6K +920 +7%
T. Rowe Price Associates
23
T. Rowe Price Associates
Maryland
$212K +$220K +12,205 New
OC
24
Oppenheimer & Co
New York
$194K -$9.63K -533 -5%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$183K +$31.6K +1,749 +20%